Deep Veins News Today

Two University Hospitals physician-scientists will receive recognition for their profound contributions to advancing clinical research. UH is the only hospital

Two University Hospitals physician-scientists will receive recognition for their profound contributions to advancing clinical research. UH is the only hospital

From mosaics to natural stone, these are the bathroom tile trends the pros are loving right now.

01.11.2023 - LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that it has entered into a definitive ...

Announces Q3 2023 Financial Results Inari to Host Conference Call Today at 1:30 P.M PT / 4:30 P.M. ET IRVINE, Calif., Nov. 01, 2023 -- Inari Medical, Inc. , a medical device company with a...

EQS Newswire / 18/09/2023 / 11:40 CET/CEST SINGAPORE - Media OutReach - 18 September 2023 - M&L Healthcare, in its first major MedTech investment, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of the LimFlow System - a revolutionary thera...

New therapeutic option has potential to reduce rate of major limb amputation in US

Revolutionary limb saving procedure set to benefit patients with Chronic Limb-Threatening Ischemia, typically caused by Type 2 DiabetesSINGAPORE - Media OutReach - 15 September...

The transcatheter stent-like device diverts arterial flow to the lower-extremity venous system to treat no-option patients with chronic limb-threatening ischemia.

1. Major amputation and all-cause mortality were higher in the vein bypass group compared to the best endovascular treatment group. 2. Cardiovascular and respiratory-related events contributed to most morbidity and mortality cases. Evidence Rating Level: 1 (Excellent) Study Rundown: Chronic limb ischemia is the most severe form of peripheral arterial disease which often requires invasive